Suppr超能文献

标准辐射剂量测定模型:介入放射科医生需要了解的内容。

Standard Radiation Dosimetry Models: What Interventional Radiologists Need to Know.

作者信息

Webster Linzi Arndt, Villalobos Alexander, Majdalany Bill S, Bercu Zachary L, Gandhi Ripal T, Kokabi Nima

机构信息

Division of Interventional Radiology and Image-Guided Medicine, Department of Radiology and Imaging Sciences, Emory University School of Medicine, Emory University School of Medicine, Atlanta, Georgia.

Miami Cardiac and Vascular Institute, Miami Cancer Institute, Miami, FL.

出版信息

Semin Intervent Radiol. 2021 Oct;38(4):405-411. doi: 10.1055/s-0041-1732323. Epub 2021 Oct 7.

Abstract

Thoughtful and accurate dosimetry is critical to obtain the safest and most efficacious yttrium-90 (Y90) radioembolization of primary and secondary liver cancers. Three dosimetry models are currently used in clinical practice, namely, body surface area model, medical internal radiation dose model, and the partition model. The objective of this review is to briefly outline the history behind Y90 dosimetry and the difference between the aforementioned models. When applying these three models to a single case, the differences between them are further demonstrated. Each dosimetry model in clinical practice has its own benefits and limitations. Therefore, it is incumbent upon practicing interventional radiologists to be aware of these differences to optimize treatment outcomes for their patients.

摘要

精确且周全的剂量测定对于实现原发性和继发性肝癌最安全、有效的钇-90(Y90)放射性栓塞治疗至关重要。目前临床实践中使用三种剂量测定模型,即体表面积模型、医学内照射剂量模型和分区模型。本综述的目的是简要概述Y90剂量测定背后的历史以及上述模型之间的差异。将这三种模型应用于单个病例时,它们之间的差异会进一步显现。临床实践中的每种剂量测定模型都有其自身的优点和局限性。因此,执业介入放射科医生有责任了解这些差异,以便为患者优化治疗效果。

相似文献

1
Standard Radiation Dosimetry Models: What Interventional Radiologists Need to Know.
Semin Intervent Radiol. 2021 Oct;38(4):405-411. doi: 10.1055/s-0041-1732323. Epub 2021 Oct 7.
2
Yttrium-90 radioembolization using MIRD dosimetry with resin microspheres.
Eur Radiol. 2021 Mar;31(3):1316-1324. doi: 10.1007/s00330-020-07231-8. Epub 2020 Sep 8.
3
Insights into handling and delivery of Y-90 radioembolization therapies.
Front Nucl Med. 2023 Mar 21;3:1075782. doi: 10.3389/fnume.2023.1075782. eCollection 2023.
4
Y90 Radioembolization Dosimetry: Concepts for the Interventional Radiologist.
Tech Vasc Interv Radiol. 2019 Jun;22(2):100-111. doi: 10.1053/j.tvir.2019.02.011. Epub 2019 Feb 27.
5
History and Evolution of Yttrium-90 Radioembolization for Hepatocellular Carcinoma.
J Clin Med. 2019 Jan 7;8(1):55. doi: 10.3390/jcm8010055.
6
Techniques to Optimize Radioembolization Tumor Coverage.
Semin Intervent Radiol. 2024 Mar 14;41(1):16-19. doi: 10.1055/s-0043-1778659. eCollection 2024 Feb.
8
Conventional Hepatic Volumetry May Lead to Inaccurate Segmental Yttrium-90 Radiation Dosimetry.
Cardiovasc Intervent Radiol. 2021 Dec;44(12):1973-1985. doi: 10.1007/s00270-021-02898-y. Epub 2021 Aug 19.
10
MIRD Pamphlet No. 29: MIRDy90-A Y Research Microsphere Dosimetry Tool.
J Nucl Med. 2024 Feb 22;65(5):794-802. doi: 10.2967/jnumed.123.266743.

引用本文的文献

本文引用的文献

2
Yttrium-90 Radioembolization Dosimetry: What Trainees Need to Know.
Semin Intervent Radiol. 2020 Dec;37(5):543-554. doi: 10.1055/s-0040-1720954. Epub 2020 Dec 11.
4
Yttrium-90 radioembolization using MIRD dosimetry with resin microspheres.
Eur Radiol. 2021 Mar;31(3):1316-1324. doi: 10.1007/s00330-020-07231-8. Epub 2020 Sep 8.
8
Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma.
J Hepatol. 2019 Dec;71(6):1164-1174. doi: 10.1016/j.jhep.2019.08.006. Epub 2019 Aug 14.
9
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma.
J Hepatol. 2018 Jul;69(1):182-236. doi: 10.1016/j.jhep.2018.03.019. Epub 2018 Apr 5.
10
SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma.
J Clin Oncol. 2018 Jul 1;36(19):1913-1921. doi: 10.1200/JCO.2017.76.0892. Epub 2018 Mar 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验